Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
Find Your Distributors

Select Your Country or Region

 $ USD

Product Inquiry: sales@probechem.com
Order/PO receiving: order@probechem.com

You are here:Home-Chemical Inhibitors & Agonists-Apoptosis-Bcl-2-Disarib
Disarib

Chemical Structure : Disarib

CAS No.: 1998149-15-7

Add to Favorites

Disarib (BCL2-BAK inhibitor Disarib)

Catalog No.: PC-62553Not For Human Use, Lab Use Only.

Disarib is a novel BCL2-specific inhibitor that binds predominantly to the BH1 domain, demonstrates strong affinity to BCL2, but not to other antiapoptotic BCL2 family members(BCL-xL, BCL2A1 etc.).

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
200 mg Get quote
1 g Get quote
Get Quotation Now
* Please select Quantity before adding items.
 or Bulk Inquiry

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    Disarib is a novel BCL2-specific inhibitor that binds predominantly to the BH1 domain, demonstrates strong affinity to BCL2, but not to other antiapoptotic BCL2 family members (BCL-xL, BCL2A1 etc.).
    Disarib is a novel BCL2 inhibitor with a unique mechanism of BCL2 inhibition.
    Disarib shows selective cytotoxicity in BCL2 high cancer cell lines, and CLL patient primary cells, as compared to BCL2 low cell lines.
    Disarib induces apoptosis by disruption of BCL2-BAK interaction with Ki of 12.76 nM, but not that of BCL2-BAX or other members of the proapoptotic family such as PUMA and BIM, in vitro.
    Disarib abrogates tumor growth while sparing platelets, by activating intrinsic pathway of apoptosis.

    Physicochemical Properties

    M.Wt 547.855
    Formula C26H16BrClN4OS
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20 °C 12 Months; 4°C 6 Months
    In Solvent
    -80 °C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO
    Chemical Name/SMILES

    3-((2-(4-chlorobenzyl)-6-(4-bromophenyl)imidazo[2,1-b][1,3,4] -thiadiazol-5-yl)methylidene)-1,3-dihydro-2H-indol-2-one

    References

    1. Iyer D, et al. FEBS J. 2016 Sep;283(18):3408-37.

    2. Vartak SV, et al. Biochem Pharmacol. 2016 Dec 15;122:10-22.

    3. Vartak SV, et al. Biochem Pharmacol. 2017 May 1;131:16-28. doi:

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: